Carpou Bill 4

What Happened
Bill Carpou, a director of MOBIX LABS, received equity awards (Restricted Stock Units) in two grant transactions: 14,805 RSUs granted on Feb 25, 2026 and 5,000 RSUs granted on Mar 30, 2026. Both awards show an acquisition price of $0.00 (typical for RSU grants); the Feb 25 RSUs vested on April 1, 2026. The share counts reported have been adjusted to reflect a 1-for-10 reverse stock split effected by the company on April 6, 2026.

Key Details

• Transaction types: Awards/Grants (Form 4 code A).
• Dates: Feb 25, 2026 (14,805 RSUs); Mar 30, 2026 (5,000 RSUs).
• Price: $0.00 (no cash paid by the insider for these RSUs).
• Vesting: Feb 25 grant vested on Apr 1, 2026 (per footnote).
• Reverse split: Counts adjusted for a 1-for-10 reverse split on Apr 6, 2026 (per footnote/remarks).
• Options note: filing also states certain options are fully vested and exercisable (footnote F3), though option exercise is not part of these reported transactions.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Filing timeliness: Form filed May 4, 2026 — more than two business days after the Feb 25 and Mar 30 grants, so this Form 4 appears to have been filed late under standard Form 4 deadlines.

Context
RSU grants are compensation awards, not open-market purchases or sales, and do not by themselves signal the insider buying or selling stock. The Feb 25 RSUs vested on Apr 1, at which point they typically convert into shares subject to any tax withholding or company rules; future sales of those vested shares would be reported separately. The reverse split simply changes reported share counts and exercise prices for clarity and does not alter the economic interest beyond consolidation.